Learn More
Medchemexpress LLC 4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluorom | 939375-07-2 | 99.9% | 420.39 | 100 MG

Supplier: Medchemexpress LLC HY16434100MG
DGAT1-IN-3 is a potent, selective, and orally bioavailable inhibitor of DGAT-1. It can be used for research on obesity, dyslipidemia, and metabolic syndrome.
- Potent, selective, and orally bioavailable inhibitor of DGAT-1.
- Inhibits human DGAT-1 with an IC50 of 38 nM.
- Inhibits rat DGAT-1 with an IC50 of 120 nM.
- Supports research into obesity.
- Supports research into dyslipidemia.
- Supports research into metabolic syndrome.
- Reduces cumulative body weight gain in DIO rats.
- Reduces weight gain and plasma triglycerides.
- Improves lipid profiles.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.